Loading...

Grifols, S.A.

GIFLF•PNK
Healthcare
Drug Manufacturers - General
$12.90
$2.33(22.04%)
U.S. Market opens in 7h 53m

Grifols, S.A. (GIFLF) Stock Overview

Explore Grifols, S.A.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap8.8B
P/E Ratio18.83
EPS (TTM)$0.69
ROE0.08%
Fundamental Analysis

AI Price Forecasts

1 Month$11.99
3 Months$14.19
1 Year Target$13.93

GIFLF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Grifols, S.A. (GIFLF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 6.26, suggesting the stock is in an oversold condition. Our forecasting models predict significant price movements, with a 12-month target of $13.93.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 18.83 and a market capitalization of 8.8B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
22.04%
5-Day Change
22.04%
1-Month Change
N/A
3-Month Change
10.63%
6-Month Change
-7.19%
Year-to-Date (YTD) Change
10.63%
1-Year Change
51.76%
3-Year Change
9.69%
5-Year Change
-54.74%
All-Time (Max) Change
-99.94%

Contact Information

https://www.grifols.com
34 93 571 02 21
Avinguda de la Generalitat, 152, Barcelona, NaN, 08174

Company Facts

23,833 Employees
IPO DateJun 24, 2008
CountryES
Actively Trading

Frequently Asked Questions